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      On the basis of chemical evidence and spectroscopic investigations, the structure and absolute 
  configuration of macrocalyxoformin E, which had been isolated from Rabdosia macrocalyx (Dunn.) 
  Hara form (Labiatae) were established as ent-6,20: 7,20a-diepoxy-6a, 15a-dihydroxy-7-oxo-6,7-seco-16-
  kaurene (5). 
     KEY WORDS: Robdosia macrocalyx (Dunn.) Hara form/ Diterpenoid/ 
                   Macrocalyxoformin E/ 6, 7-Secokaurene/ A Ring Confor-
                 mation/ Absolute configuration/ Hydride Shift/ 
     From the leaves of Rabdosia macrocalyx (Dunn.) Hara form (Labiatae), five new 
  diterpenoids, macrocalyxoformin A-E (1-5), have been isolated and their structures 
  have been previously reported2). Among these, the structure of macrocalyxoformin 
  E (5) has been speculated without sufficient chemical or spectral evidence, leaving 
  ambiguity in the configuration of several functional groups. We reexamined the 
 structure of macrocalyxoformin E and clarified the whole structure including the 
 A ring conformation and the absolute configuration. Here, we describe the struc-
  ture elucidation of macrocalyxoformin E. 
     In the previous report2), it was speculated that macrocalyxoformin E (5) has 
  an ent-6, 7-seco-16-kaurene skeleton and, has an internal acetal group at C-20 form-
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ing a lactone ring, a hemiacetal group at C-6, and an allyl alcohol on the D ring. 
However, there is no decisive evidence for the stereochemistry of the functional groups 
at C-6, C-15, and C-20 and for the absolute configuration of 5. At first, we examin-
ed several chemical reactions to get some chemical evidence for the structures of 
macrocalyxoformin E. The oxidation of 5 with manganese oxide  afforded a, 19-
unsaturated ketone 6. This reaction proved the existence of an allylic alcohol system 
on the D ring. If the hydroxyl group of the allylic alcohol system is located on the 
endo (j9)-side of the C/D ring system, the allylic alcohol system will be converted to 
the methyl ketone 7 by the Garryfoline-Cuauchichicine rearrangement') under 
acidic conditions. The reaction of 5 with p-toluenesulfonic acid in methanol caused 
the above rearragement, involving the stereoselective hydride shift from the exo-H 
at C-15 to the exo-H at C-16 through the nonclassical carbonium ion 9, to give 
methyl ketone 8 with concomitant acetalization at C-6. Because of this rearrange-
ment, the stereochemistry of the hydroxy group at C-15 was proved to be endo (fi-
configuration). Methyl acetalization under acidic conditions should proceed via 
the oxonium ion 10 which is attacked by the nuclepohile (MeOH) from the less 
hindered (Q)-side to give the acetal 8. Since the coupling constants of C-6-H in 
compounds 5 and 8 showed the same value (ca. 6 Hz) in 1H-NMR spectra, the above 
speculation leads to a'9-configuration for C-6-OH of 5. Attempted catalytic hydro-
genations of 5 afforded the keton 7 unexpectedly through the same type of rearrange-
ment') 
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   Next, we conducted the nuclear Overhauser enhancement (NOE) experiment 
on 5 to determine the configuration of C-20. Two kinds of ring A conformation (A 
and B) have been shown to exist in the Rabdosia diterpenoids of the spirolactone-
type.° Each conformer is distinguishable from the other by the NOE between 18-
H3 and 9-H or between 19-H3 and 20-H. The chemical shifts of the protons requir-
ed for the NOE inspection is easily determined from the 1H-1H correlation spectros-
copy (COSY) NMR spectrum (Fig. 1). The results of NOE experiment on 5 are 
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shown in Table 1. The NOEs  (12% and 2%) between 18-H3 and 9-H (run 1 and 
4) indicate that the A ring of 5 exists in the A conformation. The NOEs between 
C-5-H and C-9-H, and between C-20-H and C-14-H are expected in the structure 
C, while the NOEs between C-5-H, C-9-H and C-20-H are also expected in the 
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      Fig. 1. 1H-1H COSY Spectrum of Macrocalyxoformin E(5) in CDCI3 CSDSN(2: 1). 
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                   Table 1. NOE data for macrocalyxoformin E (5)a
           runMonitor protonObserved protonb (8, ppm)(Intensity increase) 
      118-H35-H, 9-H 
                        (0.97)(8.6%) (11.7%)
       219-H35-H, 6-H, 18-H3 
                        (1.03)(7.8%) (13.7%) 
       35-H9-H, . 18-H3f 19-H3 
                       (1.86)(12.5%) (1.2%) (1.4%)
      49-H5-H, 18-H3 
                       (2.75)(14.3%) (1.8%)
     520-H14a-H 
                       (5.50)(6.7%) 
      614a-H20-H, 13-H 
                        (1.71)(9.8%) 
             a, Spectra at 400 MHz NMR; solution in CDC13-05D5N (2:1). 
              b, The existence of the observed protons without any % of intensity 
               increase was indicated by the subtractive spectra from the NOE 
                experiment. 
structure D. The NOE experiment in Table 1 (run 3-6) coincides with the former 
structure C. Thus, the relative configuration of all functional groups in the structure 
5 was established. 
   Finally, in order to determine the absolute configuration of macrocalyxofor-
min E, the circular dichroism (CD) spectrum of its rearranged product 9 was measur-
ed. On the basis of a negative Cotton effect at 306 nm on the CD curve), the ab-
solute configuration of macrocalyxoformin E was established as that shown as 5. 
Consequently, the structure of macrocalyxoformin E should be represented as ent-6, 
20:7,20a-diepoxy-6a,15a-dihydroxy-7-oxo-6,7-seco-16-kaurene (5). 
                      EXPERIMENTAL SECTION 
   The melting points were determined on a Yanagimoto melting pionts apparatus 
and are uncorrected. Infrared (IR) spectra were recorded with a JASCO IR-810 
spectrophotometer, and ultraviolet (UV) spectra were taken with a JASCO UVI-
DEC-610C spectrophotometer. Optical rotations were measured with a JASCO 
DIP-181 digital polarimeter, and CD spectra were measured with a JASCO J-600 
spectropolarimeter. Mass spectra (MS) and the fast atom bombardment mass 
spectra (FAB-MS) were determined on a JEOL JMS-DX300 mass spectrometer. 
'H-NMR spectra and 13C-NMR spectra were measured with a JEOL GX-400, Va-
rian VXR-200, and JEOL FX-100, and recorded in 8 values with tetramethylsilane 
as an internal reference. Kieselgel 60 (0.05-0.2 mm, Merk) was used for column 
chromatography and precoated silica gel plates F25, (0.25 and 0.5 mm in thickness) 
were used for thin layer chromatography (TLC). 
   Isolation—Dried leaves (5Kg) of R. macrocalyx (Dunn.) Hara form collected in 
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  the southern district of Anhui (China) in August,  1985,were extracted with ethanol 
   (40 1) under reflux for 3h. The plant material was further extratced 2 times in the 
  same manner. The combined ethanol extract was concentrated under reduced 
  pressure to 20 1. The extract was treated with activated charcoal (350 g), and 
  evaporated under reduced pressure to give a sirupy residue which was dissolved in 
  boiling ethylacetate (8 1) . The ethylacetate solution was shaken with 5% aqueous 
Na2CO3 (2 1) to remove any acidic substances. After being washed with water and 
  dried with anhydrous Na2SO4, the ethylacetate extract was concentrated under 
  reduced pressure to sirupy residue (200 g), which was chromatographed on a silica 
  gel (1.2 Kg) column with chloroform-acetone. The eluates (1.5 g) from choroform-
  acetone (9:1) were rechromatographed on silica gel (100g) with dichloromethane-
  acetone as eluants. The eluates (500 mg) from dichloromethane-acetone (9:1) was 
  recrystsllized from methanol to give macroclyxoformin E (5) (100 mg). 
      Macrocalyxoformin E (5); colorless needless, mp 242-244°C, [a]D-164.5° 
(c=0.23, McOH). IR vmBX cm': 3490, 3400, 1740, 1665, 1055, 1000. 1H-NMR 
  (GX-400, CDC13: C5D5N=1:1) 8: 0.95, 1.04 (each 3H, s, 18-H3 and 19-H3), 2.76 
  (1H, br.s, 13-H), 2.81 (1H, d, J=6.8, 9-H), 5.08 (1H, d, J=2.4, 17-Ha), 5.35 (1H, 
  br.s, 15-H), 5.45 (1H, br.s, 17-Hb), 5.57 (1H, s, 20-H), 5.63 (1H, d, J=5.9, 6-H). 
13C-NMR (FX-100, C5D5N) 8: 19.3 (t), 20.9(t), 26.8(t), 27.3 (q, C-19), 30.1 (s), 
  30.9 (q, C-18), 33.0(t), 33.8(t), 34.0(t), 35.7(d), 39.9 (d), 48.2 (s), 51.9 (s), 60.7 (d), 
  75.6(d, C-15), 101.7 (d, C-20), 105.9(t, C-17), 107.2 (d, C-6), 156.0 (s, C-16), 173.6 
  (s, C-7). FAB-MS m/z: 371 (M++Na). Anal. calcd for C20H28O5: C, 68.96; H, 8.04. 
  Found: C, 68.72; H, 8.18. 
      Oxidation of macrocalyxoformin E (5)-------To a solution of macro-
  calyxoformin E (5) (10 mg) in acetone (3 ml) was added active MnO, (50 mg). 
  The mixture was stirred for 4h at room temperature, then filtered and washed with 
  acetone. After evaporation of the filtrate under reduced pressure, the residue was 
  chromatographed on a preparative TLC plate with CHC13-Me2CO (8:2) to afford 
  6 (5 mg). Recrystallization with methanol gave 6 as colorless prisms, mp 215-217°C. 
IR vmaXl3 cm-1: 3570, 1765, 1720, 1645, 1300. UV gig,' mg: 235 (e =7 ,200). 
                                                               'H-NMR (VXR-200, C5D5N)8: 0.85, 1.08 (each 3H, s, 18-H3 and 19-H3), 2.55 
(1H, d, J=6, 5-H), 3.06 (1H, br.s, 13-H), 5.30 (IH, s, 17-Ha), 5.62 (1H, s, 20-H), 
  5.68 (1H, d, J=6, 6-H), 6.05 (1H, s, 17-Hb). High MS Calcd for C20H28O5(M+): 
  346.1779. Found 346.1763. 
     Acidic Treatment of 5------To a solution of macrocalyxoformin E (5) 
  (10 mg) in methanol (3 ml) was added p-toluenesulfonic acid (8 mg). The mixture 
  was refluxed for 15h under nitrogen atmosphere and the mxiture was poured into 
  ice-water, and extracted with CH2Cl2. After the usual treatment, the extract was 
  concentrated in vacuo to give a residue which was chromatographed on a preparative 
  TLC plate with CHC13-Me2CO (9:1) to give 8 (8 mg). The product was recrystal-
  lized with McOH, mp 196-198°C. CD (c=0.2, McOH) [O]25 (nm) : —1, 450 (306) 
  (negative maximum). IR vmaz'3 cm ':1770, 1726, 1250, 1100. 1H-NMR (FX-100, 
  CDC13) 8: 0.94 (6H, s, 18-H, and 19-H3), 1.14 (3H, d, J=7, 17-H3), 3.43 (3H, s, 
-OMe), 4.90 (1H, d, J=6, 6-H), 5.40 (1H, s, 20-H). High MS Calcd for C21H30O5 
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(Mt) : 362.2093. Found 326.2125. 
   Rearragement Reaction of 5------To a solution of macrocalyxoformin E 
(5) (10 mg) in methanol (3 ml) was added a catalytic amount of 10% Pd-carbon and 
the mixture was stirred under the atmospheric pressure of hydrogen at room tem-
perature overnight. The catalyst was filtered off, and the filtrate was evaporated 
in vacuo to give a crystalline product 7 (9 mg), which was recrystallized from McOH 
to give colorless prisms, mp 238-240°C, IR vmad13 cm-': 3575, 1770, 1725, 1245, 
1127, 982. 1H-NMR (VXR-200, C5D5N) S: 0.82, 1.10 (each 3H, s, 18-H3 and 19-
H3), 1.08 (3H, d, J=7, 17-H3), 5.67 (1H, s, 20-H), 5.72 (1H, d, J=6, 6-H). High 
MS Calcd for C20H23O5 (M+) : 348.1925. Found 348.1919. 
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